<-- Back to proposed bills

Covid-19 Vaccine Damage Payments Bill

20 October 2023

Proposing MP
Christchurch
Type
Bill Debate

At a Glance

Issue Summary

Christopher Chope is moving the Second Reading of the Covid-19 Vaccine Damage Payments Bill, addressing compensation for those injured by covid-19 vaccinations. Christopher Chope is discussing a Bill aimed at addressing inadequate compensation for those harmed by the COVID-19 vaccine. Christopher Chope is discussing the Covid-19 Vaccine Damage Payments Bill, addressing issues related to compensation for those who have suffered adverse effects from the vaccine. Christopher Chope discusses the need for the UK government to provide compensation for adverse reactions to Covid-19 vaccines. The statement addresses concerns over the safety of COVID-19 vaccines and calls for transparency in communication about vaccine risks. The speaker discusses the safety of the COVID-19 vaccine and its effectiveness in reducing deaths and severe illness, while also addressing concerns about the Vaccine Damage Payment Scheme (VDPS) delays. The statement addresses the debate on the Covid-19 Vaccine Damage Payments Bill and acknowledges that while vaccinations are crucial for public health, there have been rare cases of harm caused by covid vaccines. The statement discusses issues related to the Covid-19 Vaccine Damage Payment Scheme and addresses concerns about eligibility criteria, appeal processes, and the role of the Medicines and Healthcare products Regulatory Agency (MHRA). Christopher Chope discusses concerns about the vaccine damage payment scheme and its adequacy in addressing adverse effects from covid-19 vaccines. Christopher Chope proposes to adjourn the debate on the Covid-19 Vaccine Damage Payments Bill.

Action Requested

Chope requests that the Government address the issue promptly and not delay action until after a public inquiry next year. He suggests reducing the disability threshold to provide more reasonable compensation under the scheme.

Key Facts

  • Chope first raised this issue in the House on June 21, 2021.
  • As of September 19, 2023, there were 6,809 claims made under the vaccine damage payment scheme related to covid-19 vaccines and only 251 for other illnesses (including 15 for MMR).
  • Of those 6,809 claims, 363 cases have been accepted where disabilities suffered are a direct consequence of the vaccine.
  • Chope's Bill aims to reduce the disability threshold from 60% to 20%.
  • The Bill aims to reform vaccine damage payment schemes.
  • The current maximum payment is £120,000 which does not cover all consequential losses.
  • Some individuals have been waiting over 18 months for their applications to be processed.
  • There are hundreds of outstanding medical note requests beyond the statutory one-month limit.
  • Chope's view is that changes should be retrospective for those whose claims have already been dealt with.
  • The £120,000 payment has not been increased since 2007.
  • A 60% disability under personal injury guidelines would result in damages between £105,000 and £137,000 plus consequential loss.
  • Oxford University’s Centre for Socio-Legal Studies describes the Vaccine Damage Payments Act 1979 as a 'no-fault compensation scheme'.
  • Germany is paying significant sums to people adversely affected by vaccines.
  • The House voted to mandate vaccines for care workers in July 2021.
  • Plan B was introduced in December 2021, including vaccine passports for large gatherings.
  • Pfizer/BioNTech covid-19 vaccine safety information mentions myocarditis and pericarditis occurring in some recipients.
  • A Moderna mRNA covid vaccine trial involving healthy children aged 12 and up has been approved by the MHRA.
  • The term 'safe and effective' became ubiquitous during the pandemic, influencing public perception.
  • AstraZeneca vaccine guidelines changed due to blood clot concerns.
  • Florida recommended against mRNA vaccines for males aged 18-39 in 2021.
  • The 'First Do No Harm' report highlighted issues with the MHRA's adverse event reporting system.
  • Victims of vaccine injuries face stigma and abuse, being branded as anti-vaxxers.
  • Applicants for compensation have waited over 18 months for a decision, with some not receiving sufficient support despite disablement.
  • Over 230,000 people died with COVID-19 in the UK during the pandemic.
  • Serious adverse events related to vaccines are rare compared to doses administered.
  • Hundreds of people have waited over a year for outcomes from the VDPS, with some waiting more than 18 months.
  • The UK's vaccination programme was at the forefront of tackling covid-19 and was the first to deliver the vaccine outside clinical trials.
  • There have been extremely rare cases where individuals experienced harm following a covid vaccination.
  • The Vaccine Damage Payments Scheme (VDPS) was established in 1979 and includes a one-off tax-free payment for those harmed by certain vaccines, including covid-19 since December 2020.
  • As of July 2007, the current VDPS amount is £120,000.
  • The current eligibility for disability payments is set at 60% disablement.
  • As of October 6, 7,574 claims have been made with 3,593 processed and 149 receiving a payment.
  • On average, it takes six months to investigate and process claims.
  • The Department for Work and Pensions (DWP) has moved the scheme to NHS Business Services Authority (NHSBSA).
  • The MHRA reviewed AstraZeneca vaccine changes based on evidence from the Julia Cumberlege report.
  • There have been 6,809 claims under the vaccine damage payment scheme in respect of covid-19 between October 2021 and September 2023.
  • In contrast, there were only 35 claims for flu vaccines and nine claims for HPV vaccines during the same period.
  • Only 15 cases have been referred to the VDPS in relation to MMR vaccines.
  • Debate on the Covid-19 Vaccine Damage Payments Bill is proposed to be adjourned.
  • Module 4 of the bill is scheduled for discussion later, possibly in July next year.
  • The debate is ordered to resume on Friday 27 October.
Assessment & feedback
Summary accuracy